US2020260767A1PendingUtilityA1

Readily dissolvable steviol glycoside compositions

Assignee: CARGILL INCPriority: Oct 6, 2017Filed: Oct 5, 2018Published: Aug 20, 2020
Est. expiryOct 6, 2037(~11.2 yrs left)· nominal 20-yr term from priority
A61K 31/192A61K 36/28A23L 27/36C07K 1/18A23L 27/30C07H 15/256C07K 1/16A23L 2/68A23F 3/34A61K 31/235A23L 2/60B01D 15/361A23L 27/88A61K 2236/31A23L 2/56A23L 5/40A23V 2250/258A23V 2200/15A61K 2236/39A23L 27/39A23V 2002/00
72
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A readily dissolvable steviol glycoside composition comprising a steviol glycoside and a dissolution enhancer compound in an amount effective to increase dissolution of the steviol glycoside.

Claims

exact text as granted — not AI-modified
1 . A readily dissolvable steviol glycoside composition, the composition comprising:
 a steviol glycoside; and   a dissolution enhancer compound in an amount effective to increase dissolution of the steviol glycoside,   wherein the dissolution enhancer compound comprises at least one compound selected from the group consisting of a quinic acid, caffeic acid, ferulic acid, sinapic acid, p-coumaric acid, an ester of quinic acid, an ester of caffeic acid, an ester of ferulic acid, an ester of sinapic acid, an ester of p-coumaric acid, an ester of caffeic acid and quinic acid, an ester of caffeic acid and quinic acid comprising a single caffeic acid moiety, an ester of caffeic acid and quinic acid comprising more than one caffeic acid moiety, an ester of ferulic acid and quinic acid, an ester of ferulic acid and quinic acid comprising a single ferulic acid moiety, an ester of ferulic acid and quinic acid comprising more than one ferulic acid moiety, an ester of sinapic acid and quinic acid, an ester of sinapic acid and quinic acid comprising a single sinapic acid moiety, an ester of sinapic acid and quinic acid comprising more than one sinapic acid moiety, an ester of p-coumaric acid and quinic acid, an ester of p-coumaric acid and quinic acid comprising a single p-coumaric acid moiety, an ester of p-coumaric acid and quinic acid comprising more than one p-coumaric acid moiety, a caffeic ester of 3-(3,4-dihydroxyphenyl)lactic acid, an ester of caffeic acid and tartaric acid, an ester of caffeic acid and tartaric acid comprising a single caffeic acid moiety, an ester of caffeic acid and tartaric acid comprising more than one caffeic acid moiety, salt thereof and/or isomers thereof.   
     
     
         2 . The composition of  claim 1 , wherein the amount effective to increase dissolution of the steviol glycoside is an amount such that the dissolution enhancer compound comprises a 1:0.3 to 1:3 ratio by weight of steviol glycoside to dissolution enhancer compound. 
     
     
         3 . The composition of  claim 1 , wherein the amount effective to increase dissolution of the steviol glycoside is an amount such that the dissolution enhancer compound comprises a 1:1 to 1:3 ratio by weight of steviol glycoside to dissolution enhancer compound. 
     
     
         4 . The composition of  claim 1 , wherein the dissolution enhancer compound comprises one or more compounds selected from the group consisting of chlorogenic acid, neochlorogenic acid, cryptochlorogenic acid, 3-O-caffeoylquinic acid, 4-O-caffeoylquinic acid, 5-O-caffeoylquinic acid, 1,3-dicaffeoylquinic acid, 1,4-dicaffeoylquinic acid, 1,5-dicaffeoylquinic acid, 3,4-dicaffeoylquinic acid, 3,5-dicaffeoylquinic acid, 4,5-dicaffeoylquinic acid, 3-O-feruloylquinic acid, 4-O-feruloylquinic acid, 5-O-feruloylquinic acid, 3,4-diferuloylquinic acid, 3,5-diferuloylquinic acid, 4,5-diferuloylquinic acid, rosmarinic acid, cichoric acid, caftaric acid, monocaffeoyltartaric acid, dicaffeoyltartaric acid and salts and/or isomers thereof. 
     
     
         5 . The composition of  claim 1 , wherein the dissolution enhancer compound comprises one or more compounds selected from the group consisting of chlorogenic acid, neochlorogenic acid, cryptochlorogenic acid, 3-O-caffeoylquinic acid, 4-O-caffeoylquinic acid, 5-O-caffeoylquinic acid, 1,3-dicaffeoylquinic acid, 1,4-dicaffeoylquinic acid, 1,5-dicaffeoylquinic acid, 3,4-dicaffeoylquinic acid, 3,5-dicaffeoylquinic acid, and 4,5-dicaffeoylquinic acid. 
     
     
         6 . The composition of  claim 1 , wherein the steviol glycoside is crystalline. 
     
     
         7 . The composition of  claim 1 , wherein the steviol glycoside comprises one or more of rebaudioside M and rebaudioside D. 
     
     
         8 . The composition of  claim 1 , wherein the composition comprises less than 0.3% (wt) of malonate, malonic acid, oxalate, oxalic acid, lactate, lactic acid, succinate, succinic acid, malate, or malic acid; or less than 0.05% (wt) of pyruvate, pyruvic acid, fumarate, fumaric acid, tartrate, tartaric acid, sorbate, sorbic acid, acetate, or acetic acid; or less than about 0.05% (wt) of chlorophyll. 
     
     
         9 . (canceled) 
     
     
         10 . The composition of  claim 1 , wherein the composition is a dry mixture. 
     
     
         11 . (canceled) 
     
     
         12 . The composition of  claim 1 , wherein the composition is prepared by co-drying steviol glycoside and dissolution enhancer compound. 
     
     
         13 . The composition of  claim 1 , wherein the dissolution enhancer compound is prepared from a botanical source. 
     
     
         14 . The composition of  claim 13 , wherein the botanical source is selected from the group consisting of eucommoia ulmoides, honeysuckle,  Nicotiana benthamiana , globe artichoke, cardoon, stevia,  Stevia rebaudiana , monkfruit, coffee, coffee beans, green coffee beans, tea, white tea, yellow tea, green tea, oolong tea, black tea, red tea, post-fermented tea, bamboo, heather, sunflower, blueberries, cranberries, bilberries, grouseberries, whortleberry, lingonberry, cowberry, huckleberry, grapes, chicory, eastern purple coneflower, echinacea, Eastern pellitory-of-the-wall, Upright pellitory, Lichwort, Greater celandine, Tetterwort, Nipplewort, Swallowwort, Bloodroot, Common nettle, Stinging nettle, Potato, Potato leaves, Eggplant, Aubergine, Tomato, Cherry tomato, Bitter apple, Thorn apple, Sweet potato, apple, Peach, Nectarine, Cherry, Sour cherry, Wild cherry, Apricot, Almond, Plum, Prune, Holly, Yerba mate, Mate,  ilex paraguariensis , Guayusa, Yaupon Holly, Kuding, Guarana, Cocoa, Cocoa bean, Cacao, Cacao bean, Kola nut, Kola tree, Cola nut, Cola tree, Hornwort, Ostrich fern, Oriental ostrich fern, Fiddlehead fern, Shuttlecock fern, Oriental ostrich fern, Asian royal fern, Royal fern, Bracken, Brake, Common bracken, Eagle fern, Eastern brakenfern, dandelion, algae, seagrasses, Clove, Cinnamon, Indian bay leaf, Nutmeg, Bay laurel, Bay leaf, Basil, Great basil, Saint-Joseph's-wort, Thyme, Sage, Garden sage, Common sage, Culinary sage, Rosemary, Oregano, Wild marjoram, Marjoram, Sweet marjoram, Knotted marjoram, Pot marjoram, Dill, Anise, Star anise, Fennel, Florence fennel, Tarragon, Estragon, Mugwort, Licorice, Liquorice, Soy, Soybean, Soyabean, Soya vean, Wheat, Common wheat, Rice, Canola, Broccoli, Cauliflower, Cabbage, Bok choy, Kale, Collard greens, Brussels sprouts, Kohlrabi, Winter's bark, Elderflower, Assa-Peixe, Greater burdock, Valerian, and Chamomile. 
     
     
         15 . The composition of  claim 13 , wherein the botanical source is yerba mate. 
     
     
         16 . (canceled) 
     
     
         17 . (canceled) 
     
     
         18 . The composition of  claim 13 , wherein the botanical source is  stevia.    
     
     
         19 . (canceled) 
     
     
         20 . (canceled) 
     
     
         21 . A readily dissolvable steviol glycoside dry composition, the composition comprising:
 a steviol glycoside; and   a dissolution enhancer compound in an amount effective to increase dissolution of the steviol glycoside,   wherein the dissolution enhancer compound comprises at least one of a caffeic ester of quinic acid, a caffeic ester of 3-(3,4-dihydroxyphenyl)lactic acid, a caffeic acid ester of tartaric acid, a ferulic ester of quinic acid, and/or isomers thereof, and   wherein the composition is a dry composition.   
     
     
         22 . The dry composition of  claim 21 , wherein the dissolution enhancer compound comprises at least 15% dicaffeoylquinic acid. 
     
     
         23 . The dry composition of  claim 21 , wherein the amount effective to increase dissolution of the steviol glycoside is an amount such that the dissolution enhancer compound comprises a 1:0.3 to 1:3 ratio by weight of steviol glycoside to dissolution enhancer compound. 
     
     
         24 . The dry composition of  claim 21 , wherein the amount effective to increase dissolution of the steviol glycoside is an amount such that the dissolution enhancer compound comprises a 1:1 to 1:3 ratio by weight of steviol glycoside to dissolution enhancer compound. 
     
     
         25 . The dry composition of  claim 21 , wherein the composition comprises less than 0.3% (wt) of malonate, malonic acid, oxalate, oxalic acid, lactate, lactic acid, succinate, succinic acid, malate, or malic acid; or less than 0.05% (wt) of pyruvate, pyruvic acid, fumarate, fumaric acid, tartrate, tartaric acid, sorbate, sorbic acid, acetate, or acetic acid; or less than about 0.05% (wt) of chlorophyll. 
     
     
         26 . The dry composition of  claim 21 , wherein the caffeic ester of quinic acid comprises at least one of chlorogenic acid, neochlorogenic acid, cryptochlorogenic acid, 3-O-caffeoylquinic acid, 4-O-caffeoylquinic acid, 5-O-caffeoylquinic acid, 1,3-dicaffeoylquinic acid, 1,4-dicaffeoylquinic acid, 1,5-dicaffeoylquinic acid, 3,4-dicaffeoylquinic acid, 3,5-dicaffeoylquinic acid, or 4,5-dicaffeoylquinic acid. 
     
     
         27 . The dry composition of  claim 21 , wherein the ferulic ester of quinic acid comprises at least one of 3-O-feruloylquinic acid, 4-O-feruloylquinic acid, 5-O-feruloylquinic acid, 3,4-diferuloylquinic acid, 3,5-diferuloylquinic acid, or 4,5-diferuloylquinic acid. 
     
     
         28 . (canceled) 
     
     
         29 . (canceled) 
     
     
         30 . (canceled) 
     
     
         31 . The dry composition of  claim 21 , wherein the steviol glycoside is crystalline. 
     
     
         32 . The dry composition of  claim 21 , wherein the steviol glycoside comprises one or more of rebaudioside M and rebaudioside D. 
     
     
         33 . (canceled) 
     
     
         34 . (canceled) 
     
     
         35 . (canceled) 
     
     
         36 . The dry composition of  claim 21 , wherein the composition is prepared by co-drying steviol glycoside and dissolution enhancer compound. 
     
     
         37 . The dry composition of  claim 21 , wherein the dissolution enhancer compound is prepared from a botanical source. 
     
     
         38 - 44 . (canceled)

Join the waitlist — get patent alerts

Track US2020260767A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.